Research Solutions (RSSS) Competitors $2.94 -0.01 (-0.34%) Closing price 03:59 PM EasternExtended Trading$2.96 +0.02 (+0.82%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RSSS vs. OPRX, LTBR, PAYS, OOMA, TRAK, SHAP, IMXI, EGHT, TRVG, and AHGShould you be buying Research Solutions stock or one of its competitors? The main competitors of Research Solutions include OptimizeRx (OPRX), Lightbridge (LTBR), Paysign (PAYS), Ooma (OOMA), ReposiTrak (TRAK), Spree Acquisition Corp. 1 (SHAP), International Money Express (IMXI), 8X8 (EGHT), Trivago N.V. ADS (TRVG), and Akso Health Group (AHG). These companies are all part of the "business services" industry. Research Solutions vs. Its Competitors OptimizeRx Lightbridge Paysign Ooma ReposiTrak Spree Acquisition Corp. 1 International Money Express 8X8 Trivago N.V. ADS Akso Health Group Research Solutions (NASDAQ:RSSS) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Is RSSS or OPRX more profitable? Research Solutions has a net margin of -8.03% compared to OptimizeRx's net margin of -9.42%. OptimizeRx's return on equity of 4.50% beat Research Solutions' return on equity.Company Net Margins Return on Equity Return on Assets Research Solutions-8.03% -5.80% -1.59% OptimizeRx -9.42%4.50%3.12% Which has higher valuation and earnings, RSSS or OPRX? Research Solutions has higher earnings, but lower revenue than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Research Solutions, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioResearch Solutions$44.62M2.14-$3.79M-$0.14-21.00OptimizeRx$104.75M3.06-$18.66M-$0.54-31.94 Which has more volatility and risk, RSSS or OPRX? Research Solutions has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Do analysts recommend RSSS or OPRX? OptimizeRx has a consensus target price of $11.81, suggesting a potential downside of 31.52%. Given OptimizeRx's stronger consensus rating and higher probable upside, analysts plainly believe OptimizeRx is more favorable than Research Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Research Solutions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00OptimizeRx 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Do institutionals & insiders have more ownership in RSSS or OPRX? 33.6% of Research Solutions shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 12.9% of Research Solutions shares are owned by company insiders. Comparatively, 5.6% of OptimizeRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor RSSS or OPRX? In the previous week, Research Solutions had 4 more articles in the media than OptimizeRx. MarketBeat recorded 10 mentions for Research Solutions and 6 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.74 beat Research Solutions' score of 0.65 indicating that OptimizeRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Research Solutions 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OptimizeRx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOptimizeRx beats Research Solutions on 10 of the 16 factors compared between the two stocks. Get Research Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for RSSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RSSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RSSS vs. The Competition Export to ExcelMetricResearch SolutionsPRINTING IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$95.43M$1.59B$7.78B$9.73BDividend YieldN/A3.05%4.56%4.09%P/E Ratio-21.002.6226.1425.96Price / Sales2.141.28102.08122.97Price / Cash339.75180.2828.3758.38Price / Book8.172.704.096.39Net Income-$3.79M$47.19M$796.69M$265.56M7 Day Performance2.44%4.12%0.60%1.98%1 Month Performance3.89%-1.58%1.19%1.33%1 Year Performance6.14%1.22%27.76%21.15% Research Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RSSSResearch Solutions1.7322 of 5 stars$2.94-0.3%N/A+6.1%$95.43M$44.62M-21.00130News CoverageShort Interest ↑Analyst RevisionOPRXOptimizeRx1.2709 of 5 stars$16.18-6.5%$11.81-27.0%+88.6%$319.96M$92.13M-29.96100High Trading VolumeLTBRLightbridge0.3061 of 5 stars$13.50-2.0%N/A+459.8%$316.45MN/A-16.076Insider TradePAYSPaysign3.9681 of 5 stars$5.61flat$8.56+52.6%+9.9%$305.48M$58.38M46.7580OOMAOoma2.8162 of 5 stars$10.97-0.9%$17.63+60.7%+33.7%$305.26M$256.85M-57.711,186Upcoming EarningsTRAKReposiTrak0.8181 of 5 stars$16.57-0.6%N/AN/A$304.67M$20.45M48.7470SHAPSpree Acquisition Corp. 1N/A$10.91flatN/AN/A$283.07MN/A0.00N/AIMXIInternational Money Express3.1555 of 5 stars$14.90+60.6%$19.60+31.5%-14.8%$279.58M$658.65M8.821,303High Trading VolumeEGHT8X83.7783 of 5 stars$1.75-9.3%$2.49+42.0%+2.2%$263.19M$715.07M-10.941,942Analyst ForecastHigh Trading VolumeTRVGTrivago N.V. ADS2.6151 of 5 stars$3.45-3.4%$4.35+26.1%+57.7%$251M$498.74M-345.00710Positive NewsAHGAkso Health GroupN/A$1.73+1.2%N/A+75.2%$249.19M$2.41M0.0040 Related Companies and Tools Related Companies OptimizeRx Alternatives Lightbridge Alternatives Paysign Alternatives Ooma Alternatives ReposiTrak Alternatives Spree Acquisition Corp. 1 Alternatives International Money Express Alternatives 8X8 Alternatives Trivago N.V. ADS Alternatives Akso Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RSSS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Research Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Research Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access